Determination of active TGF-β2 in aqueous humor prior to and following cryopreservation

Molecular Vision

Volumn 12, Issue , 2006, Pages 1477-1482

  Maier, Philip ^a,b   Broszinski, Anja ^a   Heizmann, Ulrike ^a   Boehringer, Daniel ^a   Reinhard, Thomas ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA2;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CATARACT; CATARACT EXTRACTION; CONTROLLED STUDY; CORNEA DISEASE; CRYOPRESERVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FROZEN SECTION; HUMAN; HUMAN TISSUE; KERATOPLASTY; NORMAL VALUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS;

AGED; AQUEOUS HUMOR; CATARACT; CATARACT EXTRACTION; CORNEAL DISEASES; CRYOPRESERVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE DISEASES; FEMALE; GLAUCOMA; HUMANS; KERATECTOMY, PHOTOREFRACTIVE, EXCIMER LASER; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; TRANSFORMING GROWTH FACTOR BETA2;

EID: 33845743952     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Barton DE, Foellmer BE, Du J, Tamm J, Derynck R, Francke U. Chromosomal mapping of genes for transforming growth factors beta 2 and beta 3 in man and mouse: dispersion of TGF-beta gene family. Oncogene Res 1988; 3:323-31.
2. Gupta A, Monroy D, Ji Z, Yoshino K, Huang A, Pflugfelder SC. Transforming growth factor beta-1 and beta-2 in human tear fluid. Curr Eye Res 1996; 15:605-14.
3. Connor TB Jr, Roberts AB, Sporn MB, Danielpour D, Dart LL, Michels RG, de Bustros S, Enger C, Kato H, Lansing M. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest 1989; 83:1661-6.
4. Cousins SW, McCabe MM, Danielpour D, Streilein JW. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 1991; 32:2201-11.
5. Pasquale LR, Dorman-Pease ME, Lutty GA, Quigley HA, Jampel HD. Immunolocalization of TGF-beta 1, TGF-beta 2, and TGF-beta 3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci 1993; 34:23-30.
6. Granstein RD, Staszewski R, Knisely TL, Zeira E, Nazareno R, Latina M, Albert DM. Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation. J Immunol 1990; 144:3021-7. Erratum in: J Immunol 1991; 146:3687.
7. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 1987; 105:1039-45.
8. Khalil N. TGF-beta: from latent to active. Microbes Infect 1999; 1:1255-63.
9. Zamiri P, Masli S, Kitaichi N, Taylor AW, Streilein JW. Thrombospondin plays a vital role in the immune privilege of the eye. Invest Ophthalmol Vis Sci 2005; 46:908-19.
10. Neurohr C, Nishimura SL, Sheppard D. Activation of transforming growth factor-beta by the integrin alphavbeta8 delays epithelial wound closure. Am J Respir Cell Mol Biol 2006; 35:252-9.
11. Saika S. TGFbeta pathobiology in the eye. Lab Invest 2006; 86:106-15.
12. Reinhard T, Bonig H, Mayweg S, Bohringer D, Gobel U, Sundmacher R. Soluble Fas ligand and transforming growth factor beta2 in the aqueous humor of patients with endothelial immune reactions after penetrating keratoplasty. Arch Ophthalmol 2002; 120:1630-5.
13. Dekaris I, Gabric N, Mazuran R, Karaman Z, Mravicic I. Profile of cytokines in aqueous humor from corneal graft recipients. Croat Med J 2001; 42:650-6.
14. Wimmer I, Welge-Luessen U, Picht G, Grehn F. Influence of argon laser trabeculoplasty on transforming growth factor-beta 2 concentration and bleb scarring following trabeculectomy. Graefes Arch Clin Exp Ophthalmol 2003; 241:631-6.
15. de Boer JH, Limpens J, Orengo-Nania S, de Jong PT, La Heij E, Kijlstra A. Low mature TGF-beta 2 levels in aqueous humor during uveitis. Invest Ophthalmol Vis Sci 1994; 35:3702-10.
16. Inatani M, Tanihara H, Katsuta H, Honjo M, Kido N, Honda Y. Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch Clin Exp Ophthalmol 2001; 239:109-13.
17. Picht G, Welge-Luessen U, Grehn F, Lutjen-Drecoll E. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol 2001; 239:199-207.
18. Tripathi RC, Li J, Chan WF, Tripathi BJ. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res 1994; 59:723-7.
19. Jampel HD, Roche N, Stark WJ, Roberts AB. Transforming growth factor-beta in human aqueous humor. Curr Eye Res 1990; 9:963-9.
20. Thavasu PW, Longhurst S, Joel SP, Slevin ML, Balkwill FR. Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. J Immunol Methods 1992; 153:115-24.
21. Brown PD, Wakefield LM, Levinson AD, Sporn MB. Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors 1990; 3:35-43.
22. Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol 1988; 106:1659-65.
23. Cao E, Chen Y, Cui Z, Foster PR. Effect of freezing and thawing rates on denaturation of proteins in aqueous solutions. Biotechnol Bioeng 2003; 82:684-90.
24. Janciauskiene S, Brandt L, Wallmark A, Westin U, Krakau T. Secreted leukocyte protease inhibitor is present in aqueous humours from cataracts and other eye pathologies. Exp Eye Res 2006; 82:505-11.
25. Taylor AW, Alard P, Yee DG, Streilein JW. Aqueous humor induces transforming growth factor-beta (TGF-beta)-producing regulatory T-cells. Curr Eye Res 1997; 16:900-8.